- Home
- ICLR vs G Comparison
ICLR vs G Comparison
Compare ICLR & G Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICLR | G |
|---|---|---|
| Founded | 1990 | 1997 |
| Country | Ireland | Bermuda |
| Employees | N/A | 140000 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.3B |
| IPO Year | 2001 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ICLR | G |
|---|---|---|
| Price | $109.50 | $35.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $178.62 | $49.50 |
| AVG Volume (30 Days) | 753.1K | ★ 2.0M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.11% |
| EPS Growth | N/A | ★ 9.82 |
| EPS | N/A | ★ 3.13 |
| Revenue | N/A | ★ $2,279,438,000.00 |
| Revenue This Year | N/A | $9.23 |
| Revenue Next Year | N/A | $7.26 |
| P/E Ratio | $12.91 | ★ $11.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $66.57 | $33.92 |
| 52 Week High | $211.00 | $50.24 |
Technical Indicators
Market Signals| Indicator | ICLR | G |
|---|---|---|
| Relative Strength Index (RSI) | 53.21 | 37.48 |
| Support Level | $95.75 | $34.79 |
| Resistance Level | $114.75 | $45.77 |
| Average True Range (ATR) | 5.20 | 1.27 |
| MACD | 1.56 | -0.18 |
| Stochastic Oscillator | 74.22 | 32.64 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About G Genpact Limited
Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.